FINAL RESULTS OF A PHASE II STUDY OF IMATINIB MESYLATE (GLEEVEC) PLUS HYDROXYUREA FOR ADULTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA
Publication
, Conference
Reardon, DA; Peters, K; Desjardins, A; Sampson, J; Vredenburgh, JJ; Gururangan, S; Friedman, HS
Published in: NEURO-ONCOLOGY
November 1, 2010
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
November 1, 2010
Volume
12
Start / End Page
49 / 49
Location
Hollywood, FL
Publisher
OXFORD UNIV PRESS INC
Conference Name
Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Reardon, D. A., Peters, K., Desjardins, A., Sampson, J., Vredenburgh, J. J., Gururangan, S., & Friedman, H. S. (2010). FINAL RESULTS OF A PHASE II STUDY OF IMATINIB MESYLATE (GLEEVEC) PLUS HYDROXYUREA FOR ADULTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA. In NEURO-ONCOLOGY (Vol. 12, pp. 49–49). Hollywood, FL: OXFORD UNIV PRESS INC.
Reardon, David A., Katherine Peters, Annick Desjardins, John Sampson, James J. Vredenburgh, Sri Gururangan, and Henry S. Friedman. “FINAL RESULTS OF A PHASE II STUDY OF IMATINIB MESYLATE (GLEEVEC) PLUS HYDROXYUREA FOR ADULTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA.” In NEURO-ONCOLOGY, 12:49–49. OXFORD UNIV PRESS INC, 2010.
Reardon DA, Peters K, Desjardins A, Sampson J, Vredenburgh JJ, Gururangan S, et al. FINAL RESULTS OF A PHASE II STUDY OF IMATINIB MESYLATE (GLEEVEC) PLUS HYDROXYUREA FOR ADULTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2010. p. 49–49.
Reardon, David A., et al. “FINAL RESULTS OF A PHASE II STUDY OF IMATINIB MESYLATE (GLEEVEC) PLUS HYDROXYUREA FOR ADULTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA.” NEURO-ONCOLOGY, vol. 12, OXFORD UNIV PRESS INC, 2010, pp. 49–49.
Reardon DA, Peters K, Desjardins A, Sampson J, Vredenburgh JJ, Gururangan S, Friedman HS. FINAL RESULTS OF A PHASE II STUDY OF IMATINIB MESYLATE (GLEEVEC) PLUS HYDROXYUREA FOR ADULTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2010. p. 49–49.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
November 1, 2010
Volume
12
Start / End Page
49 / 49
Location
Hollywood, FL
Publisher
OXFORD UNIV PRESS INC
Conference Name
Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences